Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease - Wikidata - awgldk - TriplyDB

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

http://www.wikidata.org/entity/Q28275105

about

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease Inflammatory monocytes and the pathogenesis of viral encephalitis Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.Anti-aggregating effect of the naturally occurring dipeptide carnosine on aβ1-42 fibril formation Dealing with Danger in the CNS: The Response of the Immune System to Injury.Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease.Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators.Apolipoprotein E isoform-dependent microglia migration Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice.Telomere length is age-dependent and reduced in monocytes of Alzheimer patients.A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.Both Cerebral and Hematopoietic Deficiencies in CCR2 Result in Uncontrolled Herpes Simplex Virus Infection of the Central Nervous System in Mice.Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis.Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease.Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution.T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers.Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment.Monocytes and Alzheimer's disease The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.Microglial Aβ receptors in Alzheimer's disease.Migration of blood cells to β-amyloid plaques in Alzheimer's disease.Microglia-blood vessel interactions: a double-edged sword in brain pathologies.Spontaneous development of autoimmune uveitis Is CCR2 dependent.Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.There is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer's disease.Inhibition of hypothalamic leukemia inhibitory factor exacerbates diet-induced obesity phenotype.MCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response.Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation.Downregulation of CCL2 induced by the upregulation of microRNA-206 is associated with the severity of HEV71 encephalitis.Association of CXCL1 promoter polymorphism with ischaemic stroke in Korean population.Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.Microglial interactions with the neurovascular system in physiology and pathology.Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice.Effects of myeloablation, peripheral chimerism, and whole-body irradiation on the entry of bone marrow-derived cells into the brain.Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.

P2860

Q26781815-50D6A644-E999-408D-874D-5A7B3C13CBD3 Q26861256-F3E87554-5AEF-4BE3-B4D1-C8DB2D3CC7BB Q27303708-5B347E52-6E3C-422F-80B7-B7AD36021E97 Q28534489-7A4D2EE0-BC93-4891-B4B4-12DE21DE88DB Q30279070-3225280E-6259-475C-82BC-8C54E52C8E9F Q30572684-BF7F4921-5450-4885-AB1B-70DA12FA9991 Q30666219-14F9409F-3FD0-4D8E-A758-77D44A559E39 Q33572146-E2494E34-38DA-4ED2-8E1E-A1FB49607204 Q34268223-060D3603-E125-4C0C-B228-58E78488252B Q35003241-BFCC1FE4-73B4-4015-BB72-329B9A3A383A Q35019131-97B5A8C7-7D9D-4CEB-BAF6-9AA9332F4133 Q35058650-D8F0F277-79EE-4467-839D-B66F51F174F5 Q35754292-FCD97F0F-67B0-45E8-8D11-16A86F34CBDD Q36045119-0E935914-18A7-48FD-AAEC-32865D4416E0 Q36216207-5084386F-1500-4F9A-B34F-06DE8D9F65C5 Q36240868-E2546C3C-32A7-4478-B642-41F999E53D6F Q36371175-0F602909-BC62-41ED-A416-5277A0705F33 Q36622309-B94462F2-9601-488A-8F8F-C10330DE55F3 Q36709082-5809EF4E-B7F6-4299-B5EB-E0686163CFD8 Q37672845-6B22B0EB-FDA3-491D-82BF-1AD19A8FB3E9 Q37739368-AADDEB29-7FB4-41F4-BC27-A38AB7A49F69 Q37858417-17FBE956-F565-43E0-A227-BB7883786282 Q38177234-F2A3E241-8282-4641-AFAE-749D0033DB31 Q38242383-F6E40D44-CCCC-4774-8B5C-2BA7EAD6F4E3 Q38370756-192F03DC-25FD-4204-9B31-91B419BCD801 Q38681675-89C6BAF5-056C-4033-8ECE-5F70C67928D8 Q40279157-F81ABAD5-CDD3-490F-A0C5-0FB77F6F3BBD Q40839177-0226CD1E-BA1C-4D64-90B0-B04BB342C2F7 Q41381108-0A22381D-0069-4540-913B-E6148DFC4578 Q41595116-CBD57788-C590-4F57-BE17-84F31AC076F5 Q41874688-1F48A5A1-3B6F-4B2C-9A18-DB4480729CF6 Q41984330-AF65B5BF-00F9-4A42-BD4B-DB14CD97248D Q41996686-07FD83DD-B5F1-413E-A263-5F43C9BEE931 Q42679281-42AFEC7C-DA62-450B-837D-40082A64A5E0 Q44816669-947AA4C7-1FBB-406F-A4D0-AB23D9C1A51F Q47571147-2D3DFF33-970B-4E70-93F5-D0340BE48F3A Q47741460-36DC69BC-8977-4F54-8996-F20B91243611 Q48292563-DDE36065-2147-485A-BC56-22EB63A1879A Q48881243-9C6006C2-0A75-4731-9196-955BE667E229 Q49026083-2BFB3564-E257-480C-A82E-E92DF28B3717

P2860

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

http://www.wikidata.org/entity/Q28275105

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@ast

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@en

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@nl

type

label

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@ast

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@en

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@nl

prefLabel

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@ast

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@en

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@nl

P1433

Q28275105-242FE159-D14B-4ACA-AA9C-901171C6A8A8

P1476

Q28275105-59D3AFDF-16C5-42CD-B85A-587831ADB1BB

P2093

Q28275105-0BB63336-A070-48C3-A83B-5483D0500FA8

P2860

Q28275105-03FFD900-2533-4B14-9D64-C2ABF1D5F2CF

Q28275105-0F74ADFB-E0A1-41DF-B2EA-BD1A8EAEA144

Q28275105-20DC429B-5AB3-43E5-AD02-51162C07DE82

Q28275105-220D0685-AC71-47AD-946D-936B9D5A40D3

Q28275105-26614529-05AC-4EE5-BB55-A7520E86BE29

Q28275105-2CDB393C-310A-4100-8D0C-E5BBC45ED187

Q28275105-2D3EFD1B-5FC5-4581-B0D6-CEBA8D2703B6

Q28275105-3F6BC8C5-CA1F-4F32-A1D7-BA681FBDE2BA

Q28275105-4174C7FB-359B-487B-B892-DE39149187C2

Q28275105-434927CB-0E42-4B29-8876-2F8CFA58D614

P304

Q28275105-EF7A947B-DED8-436E-A878-0BF34D0A405C

P31

Q28275105-8B10CC7C-688C-4C9C-9C15-A98584D80FD0

P356

Q28275105-E79924C7-C79B-47CC-90AA-5ECB2CE5B8C5

P407

Q28275105-BFF296BE-D12D-40FB-A523-B16FDD15573E

P433

Q28275105-820A494D-3B12-429D-B5D7-84A90E0C31A5

P478

Q28275105-CEE50C0E-9195-4E5B-B259-53E3641CB6DF

P50

Q28275105-D433F720-66C5-47A1-9D65-9892189F537B

P577

Q28275105-FEEC3839-E8F6-494B-AE3C-A3F82E55371D

P698

Q28275105-169368A0-AA91-41BC-856F-25922DAA65A0

P921

Q28275105-5F4C8503-A13C-4AF3-973D-9F10664E044C

P932

Q28275105-5896098F-D562-4BFC-AE05-AB6CF1D0D286

P356

187152710791011982

P1433

CNS and Neurological Disorders

P1476

Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease

@en

P2093

Suzanne E Hickman

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like Receptor 7 Mitigates Lethal West Nile Encephalitis via Interleukin 23-Dependent Immune Cell Infiltration and Homing

Control of microglial neurotoxicity by the fractalkine receptor

Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques.

Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease.

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.

Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans.

Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression.

Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites

P304

168-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/187152710791011982

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Joseph El Khoury

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20205643

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3684802

http://www.w3.org/2001/XMLSchema#string